CTS trades 27.0% below Wall Street's consensus target of $73.50.
Last 12 months price action with 12-month analyst target path
The base valuation assumes CTS achieves its forward estimates and maintains a stable P/E multiple of 20.6x. This scenario reflects the blended consensus of 4 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of November 8, 2026, CTS Corporation (CTS) has a Wall Street consensus price target of $73.50, based on estimates from 4 covering analysts. With the stock currently trading at $57.87, this represents a potential upside of +27.0%. The company has a market capitalization of $1.65B.
Analyst price targets range from a low of $67.00 to a high of $80.00, representing a 18% spread in expectations. The median target of $73.50 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Hold, with 1 analysts rating the stock as a Buy or Strong Buy,3 rating it Hold, and 0 rating it Sell or Strong Sell. The bearish sentiment suggests caution about the stock at current levels.
From a valuation perspective, CTS trades at a trailing P/E of 22.7x and forward P/E of 20.6x. The forward PEG ratio of 1.32 indicates reasonable valuation for growth. Analysts expect EPS to grow +9.8% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $71.86, with bear and bull scenarios of $45.27 and $94.69 respectively. Model confidence stands at 48/100, suggesting limited visibility into future performance.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 KLICKulicke and Soffa Industries, Inc. | $3.3B | $64.01 | $62.50 | -2.4% | Buy | 16.6x | 11 |
 VICRVicor Corporation | $6.7B | $146.88 | $340.00 | +131.5% | Buy | 35.4x | 7 |
 INTTinTEST Corporation | $168M | $13.37 | $17.00 | +27.2% | Buy | 28.6x | 5 |
 PLXSPlexus Corp. | $5.1B | $192.17 | $313.33 | +63.0% | Buy | 22.1x | 19 |
 AVXAvax One Technology Ltd | $34M | $4.29 | — | — | — | — | — |
 MLABMesa Laboratories, Inc. | $718M | $128.25 | $110.00 | -14.2% | Hold | 14.1x | 8 |
 NOVTNovanta Inc. | $4.8B | $135.15 | $194.00 | +43.5% | Buy | 36.6x | 3 |
 OSISOSI Systems, Inc. | $3.2B | $196.36 | $269.50 | +37.2% | Buy | 18.8x | 18 |
 GRMNGarmin Ltd. | $55.1B | $285.57 | $320.40 | +12.2% | Hold | 26.6x | 28 |
 MCHPMicrochip Technology Incorporated | $31.7B | $58.35 | $110.50 | +89.4% | Buy | 37.2x | 46 |
Quick answers to the most common questions about buying CTS stock.
The consensus Wall Street price target for CTS is $73.5, representing 27.0% upside from the current price of $57.87. With 4 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
CTS has a consensus rating of "Hold" based on 4 Wall Street analysts. The rating breakdown is mixed, with 3 Hold ratings making up the largest segment. The consensus 12-month price target of $73.5 implies 27.0% upside from current levels.
CTS trades at a forward P/E of 20.6435x, representing a moderate valuation. With analysts targeting $73.5 (27.0% implied move), the stock appears reasonably valued with upside.
The most bullish Wall Street analyst has a price target of $80 for CTS, while the most conservative target is $67. The consensus of $73.5 represents the median expectation. Our quantitative valuation model projects a bull case target of $95 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
CTS is lightly followed, with 4 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 1 have Buy ratings, 3 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month CTS stock forecast based on 4 Wall Street analysts shows a consensus price target of $73.5, with estimates ranging from $67 (bear case) to $80 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $72, with bear/bull scenarios of $45/$95.
Our quantitative valuation model calculates CTS's fair value at $72 (base case), with a bear case of $45 and bull case of $95. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 48/100.
CTS trades at a forward P/E ratio of 20.6x based on next-twelve-months earnings estimates compared to a trailing P/E of 22.7x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are very optimistic on CTS, with a "Hold" consensus rating and $73.5 price target (27.0% upside). 1 of 4 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
CTS analyst price targets range from $67 to $80, a 18% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $73.5 consensus represents the middle ground. Our model's $45-$95 range provides an independent fundamental perspective.
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.